Chemodynamic therapy (CDT) is a promising
hydroxyl radical (•OH)-mediated
tumor therapeutic method with desirable tumor specificity and minimal
side effects. However, the efficiency of CDT is restricted by the
pH condition, insufficient H2O2 level, and overexpressed
reductive glutathione (GSH), making it challenging to solve these
problems simultaneously to improve the efficacy of CDT. Herein, a
kind of polyvinylpyrrolidone-stabilized, sorafenib-loaded copper peroxide
(CuO2-PVP-SRF) nanoparticle (NPs) was designed and developed
for enhanced CDT against tumor cells through the synergetic pH-independent
Fenton-like, H2O2 self-supplying, and GSH depletion
strategy. The prepared CuO2-PVP-SRF NPs can be uptaken
by 4T1 cells to specifically release Cu2+, H2O2, and SRF under acidic conditions. The intracellular
GSH can be depleted by SRF-induced system xc– dysfunction
and Cu2+-participated redox reaction, causing the inactivation
of GPX4 and generating Cu+. A great amount of •OH
was produced in this reducing capacity-disrupted condition by the
Cu+-mediated Fenton-like reaction, causing cell apoptosis
and lipid hydroperoxide accumulation-induced ferroptosis. They display
an excellent 4T1 cell killing outcome through the improved •OH
production capacity. The CuO2-PVP-SRF NPs display elevated
therapeutic efficiency of CDT and show good promise in further tumor
treatment applications.